QuickView for Snu114;jsessionid=E6CFEBF89F5D3CDF30ECF83CD1C05944;jsessionid=1512806CA63435E970C2502883F8A2D2;jsessionid=EA9D3B95F24A2A61E91CB862866F737C;jsessionid=65572C64C5015BA5746F661DB1D92039 (gene)

1. High RIG-I and EFTUD2 expression predicts poor survival in endometrial cancer.
2. The Spliceosome Factor EFTUD2 Promotes IFN Anti-HBV Effect through mRNA Splicing.
3. A de novo start-loss in EFTUD2 associated with mandibulofacial dysostosis with microcephaly: case re…
4. Over-activation of EFTUD2 correlates with tumor propagation and poor survival outcomes in hepatocell…
5. A novel de novo missense mutation in EFTUD2 identified by whole-exome sequencing in mandibulofacial …

There were no clinical trials for Snu114;jsessionid=E6CFEBF89F5D3CDF30ECF83CD1C05944;jsessionid=1512806CA63435E970C2502883F8A2D2;jsessionid=EA9D3B95F24A2A61E91CB862866F737C;jsessionid=65572C64C5015BA5746F661DB1D92039